Darryl Kan, MD
Sports Medicine · Honolulu, HINPI 1063524007
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,586 of the $1,832 with a category attached, or 86.5%. 9 manufacturers reported payments, led by Arthrex at 46.9% of the total. Reporting peaked in 2019 at $1,015 and has fallen 82.5% since, to $178 in 2025.
Across 46 payments — averaging $39.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$859
- Bioventus LLC$560
- Sportstek Medical, Inc$156
- Impactortho, Inc.$100
- Pfizer$54
- Ferring Pharmaceuticals Inc.$37
- plus $66 from 3 others
What the payments were for
- Travel & lodging$24713%
- Food & beverage$1,58687%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $859 |
| Bioventus LLC | 26 | $560 |
| Sportstek Medical, Inc | 2 | $156 |
| Impactortho, Inc. | 1 | $100 |
| Pfizer | 2 | $54 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Amgen | 2 | $24 |
| Orthofix Medical, Inc. | 1 | $23 |
| Baudax Bio Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,832 in reported general payments places this provider in the 60th percentile of 31 sports medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 235 | $9,404 |
| Cephalexin | 16 | $1,126 |
| Methylprednisolone | 100 | $845 |
| Diclofenac Sodium | 49 | $560 |
| Tramadol Hcl | 169 | $448 |
| Duloxetine Hcl | 19 | $396 |
| Meloxicam | 29 | $283 |
| Naproxen | 21 | $200 |
| Gabapentin | 14 | $134 |
| Ibuprofen | 15 | $105 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Honolulu
- Jeffery HarpstriteHonolulu$153K
- Alexander GarberHonolulu$43K
- Daniel LimHonolulu$28K
- Megan KubaHonolulu$9K
- Jae YouHonolulu$8K
- Jay MarumotoHonolulu$3K
- Blane ChongHonolulu$2K
- Brandon TeruyaHonolulu$2K
- Garret NoguchiHonolulu$1K
- Elizabeth IgnacioHonolulu$574
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.